Clinical trial
A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)
NCT06605105 is registered in ClinicalTrials.gov with Cybin IRL Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Long-Term Extension Trial With Optional Additional Doses of CYB003 to Assess the Safety and Long-term Efficacy in Participants With Major Depressive Disorder (EXTEND)
- Lead sponsor
- Cybin IRL Limited
- Phase
- Phase 3
- Overall status
- Enrolling by invitation
- Start date
- July 18, 2025
- Completion date
- June 6, 2028
- Enrollment
- 468 (estimated)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.